Detection of Active Inflammation Status Around Ventricular Aneurysms in Patients With Cardiac Sarcoidosis
Takuma Nanno1, Shigeki Kobayashi1, Ryosuke Yoshitomi1
1Division of Cardiology, Department of Medicine and Clinical Science, Yamaguchi University Graduate School of Medicine.
Insights
In cardiac sarcoidosis with ventricular aneurysm, 18F-FDG PET shows high uptake around the aneurysm but not within it. This pattern may help diagnose and manage this complex condition.
Area of Science:
- Cardiology
- Nuclear Medicine
- Immunology
Background:
- Cardiac sarcoidosis (CS) is an inflammatory condition affecting the heart.
- Ventricular aneurysms (VA) can complicate CS, but patterns of 18F-FDG uptake are poorly understood.
Purpose of the Study:
- To investigate the pattern of 18F-fluorodeoxyglucose (18F-FDG) accumulation in the heart using positron emission tomography (PET) in patients with CS and VA.
Main Methods:
- Prospective enrollment of 82 CS patients, with 54 active CS patients divided into VA (n=17) and non-VA (n=37) groups.
- Analysis of 18F-FDG uptake patterns in the heart, comparing uptake around and within VA, and in areas of left ventricular (LV) wall thinning.
Main Results:
- Patients with VA showed strong 18F-FDG uptake surrounding the VA, with minimal uptake within the VA center (5.1±2.1 vs. 2.2±0.6, P=0.0003).
- In non-VA patients with LV wall thinning, significant 18F-FDG accumulation was observed in thinned areas (3.1±0.8 vs. 2.0±0.6, P=0.00002).
Conclusions:
- A distinct pattern of 18F-FDG accumulation around VA, with decreased uptake within, may characterize CS with VA.
- Understanding these FDG uptake patterns can enhance CS pathophysiology insights and guide early VA treatment.
Background:
Little is known about the pattern of isotope accumulation in the heart on 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography in patients with cardiac sarcoidosis (CS) complicated by ventricular aneurysm (VA).
Methods And Results:
We prospectively enrolled 82 consecutive patients with CS; 54 patients with active CS (presence of abnormal 18F-FDG accumulation in the heart) were subdivided into VA (n=17) and non-VA groups (n=37). Strong 18F-FDG accumulation surrounding the VA and its disappearance in the VA center was observed in all patients with VA, probably because of scar formation at the VA. Peak standardized uptake value was higher around the VA than in the VA center (5.1±2.1 vs. 2.2±0.6, P=0.0003) and the VA center had no 18F-FDG accumulation (VA center: 2.2±0.6 vs. control area: 2.1±0.6, P=0.37). On the other hand, in non-VA patients with LV wall thinning (n=28), 18F-FDG accumulation was significantly high, even in the area of LV wall thinning (LV wall thinning area: 3.1±0.8 vs. control area: 2.0±0.6, P=0.00002).
Conclusions:
A pattern of strong 18F-FDG accumulation surrounding the VA and its disappearance in the VA center might be characteristic in patients with CS complicated by VA. Careful attention to FDG uptake would further elucidate CS pathophysiology and aid in the early treatment of VA.
Related Concept Videos
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Myocarditis II: Clinical Features and Diagnostic Tests
Pericarditis II: Clinical Features and Diagnostic Tests
Cardiomyopathy IV: Restrictive Cardiomyopathy


